Join us for the Genitourinary Cancers Symposium for a dynamic, multidisciplinary experience.
The Genitourinary Cancers Symposium is a specialized oncology event designed for the exchange of the latest strategies in prevention, screening, diagnosis, and treatment of prostate, renal, testicular, and urotheial cancers.
The exhibits at the Genitourinary Cancers Symposium highlight the most advanced treatments, products, and services in oncology and provide attendees the opportunity to meet with representatives from the healthcare industry, including pharmaceutical companies and advocacy groups.
Exhibit sales are underway and space is limited. The intimate exhibit area provides a level playing field for the select organizations that secure space. Posters, food service, and networking rounds are located with the exhibitors, providing ample opportunity for contact with attendees.
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization that represents physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO’s efforts also are directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. ASCO has more than 35,000 members worldwide, with international members from more than 100 countries. The Society is led by President Clifford A. Hudis, MD, of Memorial Sloan Kettering Cancer Center, and CEO Allen S. Lichter, MD.